Randall Moon, director of the UW’s Institute for Stem Cell & Regenerative Medicine (ISCRM) and professor of pharmacology, and Jason Berndt, acting instructor of pharmacology, wrote a review in the March 22 edition of Science about the promise of manipulating Wnt pathways for disease treatment.
Read the full story at UW Medicine Online News.